DEFLAZACORT

Generic: DEFLAZACORT

Upsher-Smith LaboratoriesManufacturer
ORALRoute
DEFLAZACORTActive Substance
2024-11-05Original Approval

DEFLAZACORT is FDA application ANDA216720, sponsored by UPSHER SMITH LABS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
194 reports
2
PAIN
186 reports
3
ARTHRALGIA
168 reports
4
OFF LABEL USE
152 reports
5
PYREXIA
142 reports
6
PAIN IN EXTREMITY
127 reports
7
MALAISE
125 reports
8
RHEUMATOID ARTHRITIS
125 reports
9
VOMITING
123 reports
10
HEADACHE
115 reports